PARIS, France – January 23, 2008 -- Mauna Kea Technologies, a leader in in-vivo cellular imaging, announced the closing of a $30 million financing round led by U.S.-based Psilos Group. Mauna Kea Technologies will use the proceeds to expand commercialization of its Cellvizio® technology in the US and Europe, as well as to advance additional clinical applications of the platform. Founded in 2000, Mauna Kea Technologies develops and markets Cellvizio, a fundamentally new imaging approach which improves patient care by eliminating the need for unnecessary biopsies and enhances the diagnosis of a broad range of diseases via in vivo cellular imaging... Mauna Kea Technologies' Press Release - version française du communiqué de presse -
Wednesday, March 26, 2008
Mauna Kea Technologies, a leader in in-vivo cellular imaging
PARIS, France – January 23, 2008 -- Mauna Kea Technologies, a leader in in-vivo cellular imaging, announced the closing of a $30 million financing round led by U.S.-based Psilos Group. Mauna Kea Technologies will use the proceeds to expand commercialization of its Cellvizio® technology in the US and Europe, as well as to advance additional clinical applications of the platform. Founded in 2000, Mauna Kea Technologies develops and markets Cellvizio, a fundamentally new imaging approach which improves patient care by eliminating the need for unnecessary biopsies and enhances the diagnosis of a broad range of diseases via in vivo cellular imaging... Mauna Kea Technologies' Press Release - version française du communiqué de presse -
